Electra Therapeutics Inc.
Organization details
- Legal name
- Electra Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ETRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002088082
- EIN
- 83-2193635
Board of directors
- Since 2026
-
Matthew K. Fust · DirectorSince 2026
-
Nancy Stagliano · DirectorSince 2026
-
Quehuong (Kathy) Dong · Director · President & CEOSince 2026
Chief executives
Board connections
2 of this board's directors also sit on 11 other boards. 11 are in the same sector.
-
ADARx Pharmaceuticals Inc. Same sectorvia Carl L. Gordon
-
Adicet Bio Inc. Same sectorvia Carl L. Gordon
-
ArriVent BioPharma Inc. Same sectorvia Carl L. Gordon
-
Atara Biotherapeutics Inc. Same sectorvia Matthew K. Fust
-
BlossomHill Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Compass Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Keros Therapeutics Inc. Same sectorvia Carl L. Gordon
-
MBX Biosciences Inc. Same sectorvia Carl L. Gordon
-
Neumora Therapeutics Inc. Same sectorvia Matthew K. Fust
-
Scribe Therapeutics Inc. Same sectorvia Carl L. Gordon
-
Ultragenyx Pharmaceutical Inc. Same sectorvia Matthew K. Fust
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $48,699,284
- 36 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +20,700 | $8.45 | $174,915 |
| Nov 10, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +20,700 | $8.45 | $174,915 |
| Nov 10, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +2,000 | $8.45 | $16,900 |
| Nov 10, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +2,000 | $8.45 | $16,900 |
| Nov 9, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +4,000 | $8.24 | $32,960 |
| Nov 9, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +4,000 | $8.24 | $32,960 |
| Nov 9, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +16,000 | $8.24 | $131,840 |
| Nov 9, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +16,000 | $8.24 | $131,840 |
| Nov 6, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +9,816 | $7.85 | $77,056 |
| Nov 6, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +9,816 | $7.85 | $77,056 |
| Nov 6, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +39,600 | $7.85 | $310,860 |
| Nov 6, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +39,600 | $7.85 | $310,860 |
| Nov 5, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +30,891 | $7.31 | $225,813 |
| Nov 5, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +30,891 | $7.31 | $225,813 |
| Nov 5, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +125,200 | $7.31 | $915,212 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Electra Therapeutics Inc.
Who is the CEO of Electra Therapeutics Inc.?
Quehuong (Kathy) Dong has been Electra Therapeutics Inc.'s President & CEO since September 2026.
How many directors are on Electra Therapeutics Inc.'s board?
Electra Therapeutics Inc.'s board has 4 directors: Carl L. Gordon, Matthew K. Fust, Nancy Stagliano and Quehuong (Kathy) Dong.
Are Electra Therapeutics Inc. insiders buying or selling shares?
Over the last 12 months, Electra Therapeutics Inc. insiders bought $48.7 million of shares in 36 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="electra-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.